In Q2 2025, NNIT saw a decline in revenue by 2.5% to DKK 462.2m, with negative organic growth of 1.7%. The group operating profit margin ended at 5.0%, showing improvement from the previous quarter due to cost reduction initiatives. NNIT expects to end the year within the lower end of the guided range for both organic growth and operating profit margin due to macroeconomic unrest.

Geopolitical unrest in Q2 led to a slowdown in the IT Life Science consultancy industry, impacting NNIT’s performance. The company is focusing on fewer, repeatable solutions applicable across regions within the Life Science domain to drive growth and improve profitability. Initiatives to streamline operations and reduce overhead costs are expected to have a full-year impact of around DKK 30 to 35 million.

NNIT’s President and CEO, Pär Fors, acknowledges the market challenges affecting the business in Q2 but remains optimistic about growth opportunities and profitability. The company has taken steps to enhance operational efficiency and cost management in response to the challenging environment. Strategic initiatives and a solid backlog are expected to support future performance.

Selected key figures for NNIT in Q2 2025 include a revenue decline of 2.5% to DKK 462.2m and a group operating profit margin of 5.0%. Despite the challenges faced during the quarter, NNIT continues to focus on refining its operating model and go-to-market strategy to drive growth and profitability in the IT Life Science industry.

To learn more about NNIT’s Q2 2025 financial performance and strategic outlook, investors can join the conference call scheduled for September 4, 2025, at 9:30 AM CEST. Dial-in information is provided for participants from different regions. For further inquiries, contact NNIT’s Investor Relations or Media Relations representatives for more information about the company’s operations and services offered.

Read more at GlobeNewswire: NNIT improved profitability amid negative growth